Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema

Hatem M MareyOphthalmology Department, Minoufiya University, EgyptCorrespondence[email protected]

Amin F EllakwaOphthalmology Department, Minoufiya University, Egypt

Pages 1011-1016 | Published online: 22 Jul 2011

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

KleinRKleinBEMossSEVisual impairment in diabetesOphthalmology198491196709312
PubMed Web of Science ®Google Scholar
HardyRACrawfordJBRetinaVaughnDAsburyTRiordan-EvaPGeneral Ophthalmology15th edStamford, CTAppleton and Lange1999178199
Google Scholar
Early Treatment Diabetic Retinopathy Study Research GroupPhotocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1Arch Ophthalmol1985103179618062866759
PubMed Web of Science ®Google Scholar
LeeCMOlkRJModified grid laser photocoagulation for diffuse diabetic macular edema: long-term visual resultsOphthalmology199198159416021961650
PubMed Web of Science ®Google Scholar
SutterFKSimpsonJMGilliesMCIntravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trialOphthalmology20041112044204915522370
PubMed Web of Science ®Google Scholar
AudrenFErginayAHaouchineBIntravitreal triamcinolone acetonide for diffuse diabetic macular oedema: 6-month results of a prospective controlled trialActa Ophthalmol Scand20068462463016965492
PubMedGoogle Scholar
ChunDWHeierJSToppingTMA pilot study of multiple intravitreal injections of ranibizumab in patients with center-involving clinically significant diabetic macular edemaOphthalmology20061131706171217011952
PubMed Web of Science ®Google Scholar
SearsJEHoppeGTriamcinolone acetonide destabilizes VEGF mRNA in Muller cells under continuous cobalt stimulationInvest Ophthalmol Vis Sci2005464336434116249516
PubMed Web of Science ®Google Scholar
GardnerTWAntonettiDABarberAJPenn State Retina Research GroupDiabetic retinopathy: more than meets the eyeSurv Ophthalmol200247S253S25612507627
PubMed Web of Science ®Google Scholar
ShulmanSFerenczJRGiladyGTonYAssiaEPrognostic factors for visual acuity improvement after intravitreal triamcinolone injectionEye (Lond)20072181067107016691251
PubMed Web of Science ®Google Scholar
TewariHKSonyPChawlaRProspective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disordersEur J Ophthalmol20051561962616167293
PubMed Web of Science ®Google Scholar
GregoriNZRosenfeldPJPuliafitoCAOne-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusionRetina20062688989517031288
PubMed Web of Science ®Google Scholar
KonstantopoulosAWilliamsCPNewsomRSLuffAJOcular morbidity associated with intravitreal triamcinolone acetonideEye (Lond)200721331732016710433
PubMed Web of Science ®Google Scholar
RicciFMissiroliFParravanoMArgon laser trabeculoplasty in triamcinolone acetonide induced ocular hypertension refractory to maximal medical treatmentEur J Ophthalmol20061675675717061231
PubMed Web of Science ®Google Scholar
ThompsonJTCataract formation and other complications of intravitreal triamcinolone for macular edemaAm J Ophthalmol200614162963716564796
PubMed Web of Science ®Google Scholar
AielloLPAveryRLArriggPGVascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disordersN Engl J Med1994331148014877526212
PubMed Web of Science ®Google Scholar
FunatsuHYamashitaHIkedaTVitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edemaOphthalmology20031101690169613129863
PubMed Web of Science ®Google Scholar
FunatsuHYamashitaHIkedaTAngiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disordersAm J Ophthalmol200213353754311931788
PubMed Web of Science ®Google Scholar
QaumTXuQJoussenAMVEGF-initiated blood-retinal barrier breakdown in early diabetesInvest Ophthalmol Vis Sci2001422408241311527957
PubMed Web of Science ®Google Scholar
TolentinoMJMillerJWGragoudasESIntravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primateOphthalmology1996103182018288942877
PubMed Web of Science ®Google Scholar
CunninghamETJrAdamisAPAltaweelMMacugen Diabetic Retinopathy Study Group. A Phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edemaOphthalmology20051121747175716154196
PubMed Web of Science ®Google Scholar
SoheilianMRamezaniABijanzadehBIntravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edemaRetina2007271187119518046223
PubMed Web of Science ®Google Scholar
AhmadiehHRamezaniAShoeibiNIntravitreal bevacizumab with or without triamcinolone for refractory diabetic macular edema; a placebo-controlled, readomized clinical trialGraefes Arch Clin Exp Ophthalmol200824648348917917738
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date